SILO Stock Research Snapshot: Pipeline, Catalysts, and Cash Runway

SILO Pharma Inc | Needs refresh | Last updated: 2026-06-01T17:55:29Z

TickerSILO

Market Cap5.4M

Cash RunwayRunway > 12 months

Next Catalyst2030-12-31

Public Research Snapshot

SILO Pharma Inc is a publicly tracked healthcare company. This research snapshot summarizes public information on pipeline assets, clinical trials, upcoming catalysts, SEC filings, and cash runway estimates for Unmet need (Approved).

Pipeline

Asset	Indication	Modality	Stage	Public Note
SPC-14	n/a	n/a	n/a	Public pipeline row
Valuable intellectual property	a therapeutic by targeting indications	n/a	n/a	Public pipeline row
Ketamine Implant for Fibromyalgia	n/a	n/a	Preclinical	Public pipeline row
Unmet need	n/a	n/a	Approved	Public pipeline row
Medical needs	n/a	n/a	n/a	Public pipeline row
Targeting Alzheimer’s	n/a	n/a	Preclinical	Public pipeline row
saypha® VOLUME Lidocaine	Moderate to Severe Midface Volume Deficit	n/a	Phase 3	Public pipeline row
Enzalutamide	n/a	n/a	Phase 2	Public pipeline row

Catalyst Preview

Company	Ticker	Catalyst	Timing	Asset	Confidence
		Clinical Trial Completion	2030-12-31	ALS/MND Natural History Study Data Repository	Low

Cash Runway Preview

Estimated cash runway: Runway > 12 months.

This is an automated estimate and may differ from company guidance.

Recent SEC Filings

No public filing rows are loaded yet.

Clinical Trial Activity

NCT ID	Phase	Status	Enrollment	Primary Completion
NCT02099864	Phase 2	COMPLETED	36	2019-10-01
NCT03903094	n/a	COMPLETED	6295279	2022-05-06
NCT05386030	Phase 3	COMPLETED	562	2023-10-04
NCT04896008	Phase 3	COMPLETED	173	2024-07-26
NCT05966038	n/a	RECRUITING	5000	2030-12-31

Scientific Context

literature_publication | Advancing the Field of Psychedelic Epidemiology.
literature_publication | Inflammatory markers in the emergency department and PTSD symptoms in the AURORA Study: A longitudinal cohort study.
literature_publication | Impact of Inflammation on White Matter Integrity and Functional Connectivity in Chronic Major Depressive Disorder.
literature_publication | The combination of exercise and psychedelics for the treatment of major depressive disorder.
literature_publication | Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences.

Want the full SILO research brief?

Subscribe for source-linked catalyst analysis, cash runway monitoring, and clinical trial change alerts.

Get the weekly biotech catalyst watchlist

This page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell securities. Data may be incomplete or delayed. Cash runway and catalyst timing estimates are derived from public sources and may differ from company guidance.